Metabolism and energy requirements in pantothenate kinase-associated neurodegeneration

Sarah Williams, Allison Gregory, Penelope Hogarth, Susan J. Hayflick, Melanie B. Gillingham

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Pantothenate kinase-associated neurodegeneration (PKAN) is an autosomal recessive disorder of coenzyme A homeostasis caused by defects in the mitochondrial pantothenate kinase 2. Patients with PKAN present with a progressive neurological decline and brain iron accumulation, but general energy balance and nutrition status among these patients has not been reported. To determine if defects in PANK2 change basic energy metabolism in humans, we measured body composition, resting energy expenditure, dietary intake, and blood metabolites among 16 subjects with PKAN. Subjects had a broad range of disease severity but, despite the essential role of coenzyme A in energy metabolism, the subjects had remarkably normal body composition, dietary intake and energy metabolism compared to population normal values. We did observe increased resting energy expenditure associated with disease severity, suggesting increased energy needs later in the disease process, and elevated urinary mevalonate levels.

Original languageEnglish (US)
Pages (from-to)336-341
Number of pages6
JournalMolecular Genetics and Metabolism
Issue number3
StatePublished - Nov 2013
Externally publishedYes


  • Coenzyme A
  • Hallervorden-Spatz syndrome
  • PKAN
  • Pantothenate kinase-associated neurodegeneration
  • Resting energy expenditure

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology


Dive into the research topics of 'Metabolism and energy requirements in pantothenate kinase-associated neurodegeneration'. Together they form a unique fingerprint.

Cite this